1604654

Risperidone

United States Pharmacopeia (USP) Reference Standard

• Synonim(y): R 64,766
• Wzór empiryczny (zapis Hilla): C₂₃H₂₇FN₄O₂
• Numer CAS: 106266-06-2
• Masa cząsteczkowa: 410.48
• NACRES: NA.24
• PubChem Substance ID: 329751052
• UNSPSC Code: 41116107
• MDL number: MFCD00274576

Właściwości

• grade: pharmaceutical primary standard
• agency: USP
• API family: risperidone
• manufacturer/tradename: USP
• application(s): pharmaceutical (small molecule)
• format: neat
• SMILES string: CC1=C(CCN2CCC(CC2)c3noc4cc(F)ccc34)C(=O)N5CCCCC5=N1
• InChI: 1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3
• InChI key: RAPZEAPATHNIPO-UHFFFAOYSA-N
• Gene Information: human ... DRD2(1813), HTR2A(3356), HTR2C(3358)

Opis

General description

Risperidone is a new central 5-hydroxytryptamine2 and dopamine D2 antagonist. It is used to treat agitation, aggression,and psychosis caused during demnetia. It is a neuroleptic drug. It is also an atypical antipsychotic drug which is used for treating schizophrenia.

Application

It was used as reference standard during RP-UPLC analysis for determination of risperidone related compounds in Risperdal^® Consta (risperidone long-acting injection).

Analysis Note

These products are for test and assay use only. They are not meant for administration to humans or animals and cannot be used to diagnose, treat, or cure diseases of any kind.  ​

Other Notes

Sales restrictions may apply.

Legal Information

Risperdal is a registered trademark of Johnson & Johnson

Ta strona może zawierać tekst przetłumaczony maszynowo.

Informacja o środkach bezpieczeństwa

• pictograms: GHS06
• signalword: Danger
• hcodes: H301
• Hazard Classifications: Acute Tox. 3 Oral
• Klasa składowania: 6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
• flash_point_f: Not applicable
• flash_point_c: Not applicable
• pcodes: P264 - P270 - P301 + P310 - P405 - P501